Monitor Q4 2026 for initial order revenue recognition and any subsequent distributor announcements in other developed markets. The lack of disclosed minimums or pricing limits the near-term revenue visibility.
Price Chart
Executive Summary
Microbot Medical announced a three-year exclusive distribution agreement with Medtechnica Ltd. for the LIBERTY Endovascular Robotic System in Israel, following Israeli Ministry of Health approval received in May 2026. Initial orders are anticipated in Q4 2026. This is a routine commercial milestone with no financial terms disclosed.
Key Facts
- Three-year exclusive distribution agreement with Medtechnica Ltd. for the LIBERTY System in Israel
- Israeli Ministry of Health (AMAR) regulatory approval received in May 2026
- Initial orders anticipated from Medtechnica in Q4 2026
- No financial terms, minimum commitments, or revenue figures disclosed
Financial Impact
No financial terms disclosed; initial orders expected in Q4 2026 but no dollar amounts provided
Risk Factors
- No minimum purchase commitments disclosed — revenue contribution may be immaterial
- Geopolitical risk from ongoing hostilities in Israel could disrupt distribution
- Commercial-stage execution risk for a single-use robotic system with limited market penetration
Investment Themes
Documents Analyzed
This report is based on 5 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 8-K Filing (Primary) | 0001493152-26-045866 |
| Exhibit: ex99-1.htm | 0001493152-26-045866 |
| Document: 0001493152-26-045866-index-headers.html | 0001493152-26-045866 |
| Document: 0001493152-26-045866-index.html | 0001493152-26-045866 |
| Document: 0001493152-26-045866.txt | 0001493152-26-045866 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Oct 23, 2026 3d ago | 8-K | $0.9739 $0.9417 | ▼ −3.31% | ▼ −4.02% | $0.9400 (−3.48%) |
Oct 20, 2026 6d ago | 8-K | $0.9475 $0.9401 | ▼ −0.78% | ▼ −1.31% | $0.9400 (−0.79%) |
Oct 6, 2026 20d ago | 8-K | $1.07 $1.12 | ▲ +4.67% | ▲ +4.91% | $0.9400 (−12.15%) |
Oct 6, 2026 20d ago | Press Release | $1.07 $1.12 | ▲ +4.67% | ▲ +4.91% | $0.9400 (−12.15%) |
Sep 28, 2026 28d ago | 8-K | $1.25 $1.25 | ▼ −0.40% | ▼ −0.22% | $0.9400 (−24.80%) |
Aug 11, 2026 10w ago | 8-K | $1.68 $1.74 | ▲ +3.27% | ▲ +3.02% | $0.9400 (−44.05%) |
Jul 21, 2026 13w ago | 8-K | $1.80 $1.77 | ▼ −1.67% | ▼ −1.55% | $0.9400 (−47.78%) |
Jul 7, 2026 15w ago | 8-K | $1.90 $1.87 | ▼ −1.58% | ▼ −1.27% | $0.9400 (−50.53%) |
Jun 30, 2026 16w ago | 8-K | $1.95 $1.91 | ▼ −2.05% | ▼ −1.92% | $0.9400 (−51.79%) |
Jun 16, 2026 18w ago | 8-K | $1.82 $1.88 | ▲ +3.30% | ▲ +4.55% | $0.9400 (−48.35%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers